期刊文献+

关于在我国建立视网膜母细胞瘤规范化诊疗模式必要性的思考 被引量:5

The necessity of the establishment of standardized diagnostic methodology and treatment pattern of retinoblastoma in China
原文传递
导出
摘要 通过介绍视网膜母细胞瘤新的国际诊断分期标准及常规治疗方法,比较国内、国外治疗的现状和差距,总结提出了我国视网膜母细胞瘤诊疗过程中亟待解决的问题,建议在我国建立并推广规范化的视网膜母细胞瘤诊疗模式,并强调了眼科病理诊断在视网膜母细胞瘤高危因素评估以及后续治疗中的重要指导作用。 This article describes the new international classification and routine treatment methods of retinoblastoma, compares the status and gaps between domestic and foreign treatments, summarizes and presents problems to be solved in the treatment process of retinoblastoma domestically, presents suggestions in establishing and promoting a standardized diagnostic methodology and treatment pattern in China, and emphasizes the important guiding role of pathological diagnosis in ophthalmology for retinoblastoma risk factor assessment and subsequent treatment.
作者 李彬
出处 《中华眼科杂志》 CAS CSCD 北大核心 2012年第11期961-964,共4页 Chinese Journal of Ophthalmology
关键词 视网膜母细胞瘤 肿瘤分期 医师诊疗模式 Retinoblastoma Neoplasm staging Physcian's practice patterns
  • 相关文献

参考文献29

二级参考文献193

共引文献90

同被引文献75

  • 1Shields JA, Shields CL. Retinoblastoma//Shields JA, Shields CL. Intraocular Tumors: an atlas and textbook[ M]. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2008 : 293-318.
  • 2Hemandez JC, Brady LW, Shields JA, et al. External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines [ J ]. Int J Radiat Oneol Biol Phys, 1996,35 : 125-132.
  • 3Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts ehemoreduction success [ J]. Ophthalmology, 2006,113:2276-2280.
  • 4MaeCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma: treatment mad survival in Great Britain 1963 to 2002 [ J ]. Br J Ophthalmol, 2009, 93:38-39.
  • 5Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma [ J ]. Arch Ophthalmol, 2002,120:923-931.
  • 6Kaliki S, Shields CL, Shah SU, et al. Postenueleation adjuvant chemotherapy with vineristine, etoposide, and earboplatin for the treatment of high-risk retinoblastoma [ J ]. Arch Ophthalmol, 2011,129:1422-1427.
  • 7Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study [ J ]. Arch Pathol Lab Med ,2009,133 : 1203-1209.
  • 8Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enueleated eyes and evaluation of prognostic risk factors in retinoblastoma[ J]. Arch Pathol Lab Med,2009 ,133 :1199-1202.
  • 9Kaliki S, Shields CL, Rojanaporn D, et al. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes [ J ]. Ophthalmology, 2013,120:997-1003.
  • 10Suryawanshi P, Ramadwar M, Dikshit R, et al. A study of pathologic risk factors in postehemoreduced, enueleated specimens of advanced retinoblastomas in a developing country [ J ]. Arch Path& Lab Med ,2011,135 : 1017-1023.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部